AWM
CYTR

Aevitas Wealth Management’s CytRx Corp CYTR Stock Holding History

Aevitas Wealth Management’s Portfolio CYTR Stock Details CYTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,044
Closed -$4K – 481
2018
Q3 		$4K Hold
4,044
– – ﹤0.01% 407
2018
Q2 		$5K Hold
4,044
– – ﹤0.01% 371
2018
Q1 		$6K Hold
4,044
– – 0.01% 365
2017
Q4 		$7K Buy
+4,044
New +$8.37K 0.01% 357

Other funds holding CYTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
FI
FormulaFolio Investments Grand Rapids, Michigan $299M AUM 27.65% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Aevitas Wealth Management's CYTR Position: Q4 2018 in Review

Aevitas Wealth Management sold out of CytRx Corp (CYTR) in Q4 2018, closing a stake of 4,044 shares — an estimated $4K sold.

Aevitas Wealth Management first reported a position in CYTR in Q4 2017 and held it in 4 quarters. The position peaked at $7K in Q4 2017. 36 funds tracked by Wall St. Rank hold CYTR as of Q4 2018.

  • Aevitas Wealth Management reported no remaining CytRx Corp position as of Q4 2018 after selling out during the quarter.
  • Aevitas Wealth Management sold 4,044 CytRx Corp shares in Q4 2018, an estimated $4K.
  • Aevitas Wealth Management first reported a position in CytRx Corp in Q4 2017 and held it in 4 quarters.
  • Aevitas Wealth Management's CytRx Corp position peaked at $7K in Q4 2017.
  • 36 funds tracked by Wall St. Rank held CytRx Corp as of Q4 2018.

Based on Aevitas Wealth Management's 13F filing for Q4 2018, filed 14 Feb 2019.